Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone
Bookmark
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
